PATENT CLAIM ANALYSIS

Application Number: 16426880
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-10
Patent Classification: ["435", "325000"]

Abstract:
Compositions comprising synthetic membrane-receiver complexes, methods of generating synthetic membrane-receiver complexes, and methods of treating or preventing diseases, disorders or conditions therewith.

Claim (Index 23):
The pharmaceutical composition of  claim 22 , which is formulated for intravenous administration.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 100.0
- Lexical Diversity: 1.44444
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16409576', '15925212', '16195811', '15783921', '15824877']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7438987098021825
- 35 USC 102 Novelty (BERT): 0.5991209811142032
- Combined Prediction Score: 0.7294209369333846
- Mean Citation Score: 616.762246
- Max Citation Score: 628.0691
- Similarity Product: 436.7895749272466

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test